Merit Medical Systems, Inc. (MMSI) Stock Score, Valuation & Financial Research
Merit Medical Systems, Inc. is in the Healthcare sector and Medical - Instruments & Supplies industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 42/100.
Quick answer for MMSI
Merit Medical Systems, Inc. currently has a Wall Street Score of 42/100. The stored market price is $86.14. Its financial score is 36/100. Its valuation score is 10/100. These figures are a research snapshot, not a buy or sell recommendation.
What Merit Medical Systems, Inc. does
Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedura
MMSI financial snapshot
- Wall Street Score:
- 42/100
- Current price:
- $86.14
- Market capitalization:
- $5.14B
- Revenue:
- $1.54B
- Net income:
- $139.3M
- Free cash flow:
- $212.5M
- Cash:
- $490.2M
- Total debt:
- $821.6M
- EPS:
- 2.17
- P/E ratio:
- 39.7x
- Financial score:
- 36/100
- Valuation score:
- 10/100
- Revenue score:
- 20/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $212.5M, showing positive cash generation.
- The balance sheet shows $490.2M of cash versus $821.6M of total debt, so leverage deserves attention.
What the numbers mean
Its current valuation score is 10/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 36/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research MMSI
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.